Novo Nordisk announced today that Health Canada has issued marketing authorization with conditions [Notice of Compliance with ...

Learn about semaglutide’s effectiveness and clinical trial results and whether it could be right for you in your MASH treatment plan.

For more than two years it had the entirety of the market for weight-loss drugs to itself. By 2023 sales of Wegovy had ...

Even so, in an interview with The Economist, Mr Doustdar sounded confident that Novo can recover. His prescription is to push ...

Every year in biopharma brings its share of grueling defeats, and 2025 was no different, especially for companies targeting ...

Aviceda Therapeutics ("the Company" or "Aviceda"), a clinical-stage biotechnology company developing innovative therapies for retinal diseases, today announced topline results from its SIGLEC Phase 2b ...

If you have MASH, GLP-1 medications may help treat the condition. Set yourself up for success with expert advice on diet, exercise, dose scheduling, and more.

Groundbreaking Harvard research reveals gut-produced molecules significantly influence obesity and blood sugar control. These ...

PureHealth Research today announced the launch of its new line of vein health supplements, offering a natural approach to supporting healthy circulation and promoting the appearance of ...

They improve insulin sensitivity, reduce hunger signals and help people feel fuller for longer. They don’t magically repair ...

Discover top biotech companies for 2026, featuring emerging stars and leaders set for major clinical and regulatory ...

Probiotics and turmeric are dietary supplements used for many health conditions. When taken together, they may improve gut health.